 thymosin treatment chronic hepat placebo-control pilot trial chronic hepat sever progress diseas safeti efficaci thymosin fraction thymosin-alpha prospect placebo-control trial patient chronic hepat patient histolog biochem evid activ liver diseas mo treatment posit serum hepat viru dna hbsag seven patient thymosin fraction thymosin-alpha patient placebo mo conclus studi yr serum aminotransferas level thymosin-tr patient placebo group six thymosin patient patient placebo hepat viru dna serum fisher exact test treatment replic form hepat viru dna present liver specimen placebo-tr patient thymosin-tr patient fisher exact test respons therapi signific improv peripher blood lymphocyt count vitro product interferon-gamma initi valu signific side effect patient thymosin placebo-tr patient clinic biochem serolog improv patient mo follow-up result pilot trial thymosin therapi diseas remiss cessat hepat viru replic patient chronic viral infect